Decentralized & Hybrid Clinical Trials (DCTs)

Decentralized and Hybrid Clinical Trials — The Future of Patient-Centric Research

October 26, 2025October 22, 2025 digi

Decentralized and Hybrid Clinical Trials — The Future of Patient-Centric Research Decentralized Clinical Trials: Shaping the Future of Patient-Centric Research Initiatives The traditional clinical trial model — dependent on physical sites, paper-based records, and in-person visits — is rapidly being replaced by a flexible, digital, and patient-centric approach known as Decentralized Clinical Trials (DCTs). Enabled…

DCT Operating Models & “Site-in-a-Box”: A Compliance-First Blueprint (2025)

November 7, 2025 digi

DCT Operating Models & “Site-in-a-Box”: A Compliance-First Blueprint (2025) Designing Decentralized Operating Models and Site-in-a-Box Programs That Withstand Inspection Why DCT Operating Models Matter—and the Compliance Frame That Governs Them Decentralized and hybrid clinical trials reconfigure the “site” around participants, shifting procedures into homes, local clinics, and digital touchpoints while keeping the sponsor’s obligations intact….

DCT Operating Models & Site-in-a-Box, Decentralized & Hybrid Clinical Trials (DCTs)

Home Health, Mobile Nursing & eSource: Building an Inspection-Ready DCT Backbone (2025)

November 7, 2025 digi

Home Health, Mobile Nursing & eSource: Building an Inspection-Ready DCT Backbone (2025) Home Health, Mobile Nursing, and eSource That Withstand Regulatory Scrutiny Purpose, Roles, and the Global Compliance Frame Decentralized and hybrid trials shift clinical procedures from fixed sites to homes and community settings—while retaining the same obligations for patient safety, data integrity, and oversight….

Decentralized & Hybrid Clinical Trials (DCTs), Home Health, Mobile Nursing & eSource

Telemedicine & Virtual Visits in DCTs: A Compliance-First Playbook (2025)

November 8, 2025 digi

Telemedicine & Virtual Visits in DCTs: A Compliance-First Playbook (2025) Designing Telemedicine and Virtual Visits That Withstand Regulatory Scrutiny Purpose, Principles, and the Global Frame for Telemedicine in Trials Telemedicine and virtual visits move core study interactions—screening, consent discussions, safety checks, outcome assessments, and adherence support—into secure video or audio encounters. They promise reach and…

Decentralized & Hybrid Clinical Trials (DCTs), Telemedicine & Virtual Visits

Direct-to-Patient IP & Kitting: A Compliance-First Logistics Playbook (2025)

November 8, 2025November 14, 2025 digi

Direct-to-Patient IP & Kitting: A Compliance-First Logistics Playbook (2025) Designing Direct-to-Patient Logistics and Kitting That Withstand Inspection Purpose, Models, and the Global Compliance Frame Direct-to-patient (DtP) logistics move investigational products (IP/IMP), devices, and supplies from depots to participants’ doorsteps while preserving the same obligations that apply inside a pharmacy window: identity-aligned dispensing, temperature control, tamper…

Decentralized & Hybrid Clinical Trials (DCTs), Logistics: Direct-to-Patient IP & Kitting

Remote Consent & Identity Verification in DCTs: A Compliance-First Blueprint (2025)

November 8, 2025November 14, 2025 digi

Remote Consent & Identity Verification in DCTs: A Compliance-First Blueprint (2025) Remote Consent and Identity Verification That Withstand Regulatory Scrutiny Purpose, Principles, and the Global Frame for Remote Consent Decentralized and hybrid clinical trials (DCTs) move critical interactions—screening, consent discussions, and confirmation of participant identity—outside the clinic. Remote consent is not simply “signing online.” It…

Decentralized & Hybrid Clinical Trials (DCTs), Remote Consent & Identity Verification

Sensor Strategy & Data Streams in DCTs: From Device to Decision (2025)

November 8, 2025November 14, 2025 digi

Sensor Strategy & Data Streams in DCTs: From Device to Decision (2025) Engineering Sensor Strategies and Data Streams That Withstand Regulatory Scrutiny Purpose, Principles, and a Harmonized Global Frame for Sensor-Enabled Trials Decentralized and hybrid trials increasingly rely on wearables, connected devices, and ambient data to capture outcomes and safety signals at home. These technologies…

Decentralized & Hybrid Clinical Trials (DCTs), Sensor Strategy & Data Streams

Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025

November 8, 2025November 14, 2025 digi

Regulatory Expectations for DCTs: What Inspectors Will Ask in 2025 Meeting Regulator Expectations for Decentralized and Hybrid Trials The Compliance Frame: What “Good” Looks Like for DCTs Regulators evaluate decentralized and hybrid trials against a simple standard: the same scientific validity, participant protection, and data integrity expected at an on-site visit must be demonstrated when…

Decentralized & Hybrid Clinical Trials (DCTs), Regulatory Expectations for DCTs

Inclusivity & Rural Access in DCTs: Designing Trials That Reach Everyone (2025)

November 8, 2025November 14, 2025 digi

Inclusivity & Rural Access in DCTs: Designing Trials That Reach Everyone (2025) Building Inclusive, Rural-Ready Decentralized Trials Without Compromising Compliance Why Inclusivity Matters in DCTs—and the Regulatory Frame That Supports It Decentralized and hybrid clinical trials (DCTs) promise broader reach by meeting participants where they live. That promise is realized only when inclusion is designed—not…

Decentralized & Hybrid Clinical Trials (DCTs), Inclusivity & Rural Access

Technology Validation & Usability for DCTs: Evidence You Can Explain in Five Minutes (2025)

November 9, 2025November 14, 2025 digi

Technology Validation & Usability for DCTs: Evidence You Can Explain in Five Minutes (2025) Validation and Usability in Decentralized Trials: Building Systems That Stand Up to Inspection Purpose, Scope, and the Global Compliance Frame Decentralized and hybrid clinical trials depend on a lattice of digital systems—eConsent, telemedicine, eSource/ePRO, sensor hubs, IRT/IWRS, logistics platforms, and safety…

Decentralized & Hybrid Clinical Trials (DCTs), Technology Validation & Usability